Quick ELISA Kits

Product List

+ Filter

Loading...

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

Introduction

Traditional sandwich ELISAs are notorious for multi-hour protocols and high manual errors. Multi-step solid-phase configurations introduce cumulative pipetting drift, compromising standard curve linearity. Furthermore, massive absolute value discrepancies among legacy commercial kits due to unstandardized antibodies. Quick ELISA Kits resolve this replication crisis by replacing sequential solid-phase assembly with in-solution antibody-antigen binding, delivering superior kinetic efficiency and reproducibility.

Fig.1 Type of ELISA.¹

Features of Quick ELISA Kits

Our quick ELISA kits are engineered to dismantle the operational bottlenecks of traditional assays. By restructuring the biochemical pathway, we offer several distinct improvements over legacy systems.

• 90-Minute Turnaround: Complete a full quantitative assay in under 90 minutes, compared to the standard 4-hour protocols of traditional sandwich ELISAs.
• Single-Wash Protocol: Legacy ELISAs require 3 to 4 independent wash steps. Our kits utilize only one wash step, reducing well-to-well shear forces and minimizing sample loss.
• Ready-to-Use Reagents: Traditional kits require the manual dilution of concentrated capture and detection antibodies, introducing pipetting errors. Our reagents are color-coded and pre-diluted to working concentration.
• Low Sample Volume: Requires only 50 µL of sample per well, preserving precious and limited specimens like mouse serum or pediatric cerebrospinal fluid (CSF).
• Recombinant Monoclonal Consistency: By using recombinant monoclonal pairs rather than polyclonal mixtures, we achieve a lot-to-lot coefficient of variation (CV) of less than 6%.

Quick ELISA Principle

The core of quick ELISA technology lies in in-solution liquid kinetics. Traditional sandwich ELISAs rely on a slow solid-liquid interface, where target analytes must settle onto pre-coated microplate surfaces. Quick ELISA kits bypass this steric hindrance and maximize lab efficiency.

• In-Solution Complexing: The sample containing the target analyte is added to the microplate simultaneously with a tag-conjugated capture antibody and an HRP-conjugated detection antibody.
• Rapid Liquid-Phase Kinetics: The three molecules bind in solution. Because liquid-phase molecular collision rates are higher than solid-phase interfaces, the sandwich complex reaches thermodynamic equilibrium in under an hour.
• High-Affinity Capture: The fully assembled antibody-antigen-antibody sandwich complex contains a specific affinity tag. This tag binds with near-covalent affinity to an anti-tag antibody pre-coated on the microplate wall.
• Colorimetric Quantitation: After a single wash to remove unbound materials, TMB substrate is added. The HRP enzyme catalyzes a colorimetric reaction, which is read at 450 nm.

Fig.2 Assay Flowchart of Quick ELISA Kits.

Internal Validation of ELISA Kits

In drug discovery and clinical development, an immunoassay is only as dependable as its validation profile. Our quick ELISA kits undergo rigorous characterization based on bioanalytical method validation guidelines to ensure biopharmaceutical-grade assay precision.

Spike and Recovery

Spike and recovery analysis is a critical benchmark in bioanalytical validation, designed to evaluate assay accuracy within complex biological matrices such as serum, plasma, and cerebrospinal fluid (CSF). This analysis assesses the matrix effect where background proteins, lipids, or immunoglobulins interfere with antibody-antigen binding. By comparing a spiked matrix sample to a spiked control buffer, researchers calculate the recovery percentage to ensure absolute quantitative reliability. Our kits consistently achieve recovery rates of 90% to 110%, validating that our proprietary diluent buffers neutralize matrix effects.

Linearity

Linearity of dilution measures an assay's capacity to generate a mathematically consistent, linear response across a dynamic range when high-concentration samples are serially diluted. It ensures that calculated concentration values remain independent of the specific dilution factor utilized. Our kits are engineered to maintain a linear response within a tight 80% to 120% range, ensuring accurate measurement across wide dynamic ranges.

Precision

Precision assesses the run-to-run and batch-to-batch variability of the assay, quantified by the coefficient of variation (%CV). Intra-assay precision measures well-to-well variability within a single plate, while inter-assay precision evaluates variation across different plates, days and operators. Our kits achieve an intra-assay %CV of less than 4.5% and an inter-assay %CV of less than 6.0%.

Limit of Detection (LOD)

To ensure reliable measurement of low-abundance biomarkers, we define distinct sensitivity thresholds based on the lowest analyte concentration that can be reliably distinguished from the blank background. This threshold is determined by running 20 replicates of the blank calibrator diluent. By employing high-affinity recombinant monoclonal antibodies, our kits achieve high sensitivity with picogram-level limits of detection (e.g., <5 pg/mL).

Stability

To ensure long shelf life and reliable performance during transit, our kit components are validated through freeze-thaw cycling durability and accelerated stability testing. In accelerated stability testing, unopened kits are incubated at 37℃ for 7 days, after which standard curve recovery, background signal and signal-to-noise ratio are compared against fresh controls. Our kits are guaranteed to remain stable for 12 months when stored under standard refrigeration conditions.

Contact Us

Creative Biolabs' quick ELISA kits deliver an ideal combination of speed and sensitivity. By leveraging our innovative technology, these kits accelerate drug discovery and enable reproducible protein quantitation. With assay protocols shortened to under 90 minutes and streamlined to a single wash step, biopharmaceutical and clinical researchers can generate precise data without manual bottlenecks. Please feel free to contact us for more detailed information about kits.

FAQs

Reference

1. Japp, Nicole C., et al. "Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection." Journal of Immunology Research 2021.1 (2021): 9942605. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1007/s12551-025-01346-2

For Research Use Only. Not For Clinical Use.